🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to message these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source.

Some experts said the popularity for the experimental drug could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and customer regulations, risking penalties, prosecution or prison.

Platform Reaction and Content Elimination

Based on the social media company, the service has taken down problematic material and banned related keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in strengthening compliance measures.

Digital Marketplace Operations

Investigations also found groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.

Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Item Details and Pricing

Inside these groups, posts show dark colored packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said.

Her team has already seen patients harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to potentially significant health risks”.